Text Size

Effect of Quality Improvement Tools in Congestive Heart Failure (CHF)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Abhijeet Basoor, St. Joseph Mercy Oakland Hospital
ClinicalTrials.gov Identifier:
NCT01446536
First received: September 30, 2011
Last updated: March 18, 2012
Last verified: March 2012
History of Changes
  Purpose

Hypothesis: Quality Improvement tools like "Heart Failure Discharge Checklist" which emphasizes on proper education to patients, ensure appropriate dose titration and counselling improve outcome in congestive heart failure (CHF).


Condition Intervention
Congestive Heart Failure
 Other: Checklist cohort

Study Type: Interventional
Study Design: Masking: Single Blind (Investigator)
Official Title: Decreased Readmissions and Improved Quality of Care With Use of Inexpensive Checklist in Heart Failure

Resource links provided by NLM:

MedlinePlus related topics: Heart Failure
U.S. FDA Resources

Further study details as provided by St. Joseph Mercy Oakland Hospital:

Primary Outcome Measures:
  • Readmissions [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Readmission to the hospital for CHF within 6 months of discharge

  • Dose titration [ Time Frame: patients were followed during the time of hospital stay, average of 5 days ] [ Designated as safety issue: No ]
    up titration of medications including Beta blocer, ACE inhibitor or ARB was assessed during the hospital stay


Secondary Outcome Measures:
  • Medications prescribed [ Time Frame: patients were followed during their hospital stay from admission to discharge, on an average of 5 days ] [ Designated as safety issue: No ]
    during the hospital stay and at discharge this outcome is measured/assessed


Enrollment: 96
Study Start Date: August 2008
Study Completion Date: June 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control group
This arm which was control group, was randomly selected among patients with acute decompensated heart failure in whom the checklist was not used. This group was managed as per the standard guidelines.
Active Comparator: Checklist (intervention) cohort
checklist was used in this group arbitrarily by their treating physician
 Other: Checklist cohort
CHF discharge checklist was used arbitrarily by their treating physicians in addition to the standard therapy

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients admitted to SJMO with principal diagnosis of acute decompensated heart failure

Exclusion Criteria:

  • Age less than 18 years
  • Pregnant women
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01446536

Locations
United States, Michigan
St. Joseph Mercy Oakland Hospital
Pontiac, Michigan, United States, 48341
Sponsors and Collaborators
St. Joseph Mercy Oakland Hospital
Investigators
Principal Investigator: Abhijeet Basoor, MD St. Joseph Mercy Oakland Hospital
  More Information

No publications provided

Responsible Party: Abhijeet Basoor, Cardiology Fellow, St. Joseph Mercy Oakland Hospital
ClinicalTrials.gov Identifier: NCT01446536     History of Changes
Other Study ID Numbers: 11-09-02
Study First Received: September 30, 2011
Last Updated: March 18, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by St. Joseph Mercy Oakland Hospital:
Quality
Improvement

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013